{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:36:10Z","timestamp":1770910570412,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077542","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T21:29:08Z","timestamp":1381267748000},"page":"e77542","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expression of the TEL-Syk Fusion Protein in Hematopoietic Stem Cells Leads to Rapidly Fatal Myelofibrosis in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Michelle T.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare L.","family":"Abram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford A.","family":"Lowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms","volume":"118","author":"W Vainchenker","year":"2011","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4614-6176-0_8","article-title":"Tyrosine kinase targeted treatment of chronic myelogenous leukemia and other myeloproliferative neoplasms","volume":"779","author":"A Bisen","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrd3264","article-title":"Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond","volume":"10","author":"A Quint\u00e1s-Cardama","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.leukres.2011.05.037","article-title":"The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation","volume":"35","author":"A Holroyd","year":"2011","journal-title":"Leuk Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"DL Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V97.4.1050","article-title":"Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)","volume":"97","author":"Y Kuno","year":"2001","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"A M\u00f3csai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"L Chen","year":"2008","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccr.2009.08.018","article-title":"Proteomic and genetic approaches identify Syk as an AML target","volume":"16","author":"CK Hahn","year":"2009","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"B Streubel","year":"2006","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","article-title":"T-cell signaling regulated by the Tec family kinase, Itk","volume":"2","author":"AH Andreotti","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","article-title":"The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease","volume":"70","author":"C Dierks","year":"2010","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"26871","DOI":"10.1074\/jbc.M109.034272","article-title":"The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation","volume":"284","author":"S Rigby","year":"2009","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e23620","DOI":"10.1371\/journal.pone.0023620","article-title":"The ETS family member TEL binds to nuclear receptors RAR and RXR and represses gene activation","volume":"6","author":"MA Meester-Smoor","year":"2011","journal-title":"PLOS ONE"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","article-title":"ETV6: a versatile player in leukemogenesis","volume":"15","author":"SK Bohlander","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1084\/jem.20060967","article-title":"Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells","volume":"203","author":"T Wossning","year":"2006","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.leu.2403266","article-title":"TEL-Syk fusion constitutively activates PI3-K\/Akt, MAPK and JAK2-independent STAT5 signal pathways","volume":"18","author":"T Kanie","year":"2004","journal-title":"Leukemia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ni1407","article-title":"Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs","volume":"7","author":"A M\u00f3csai","year":"2006","journal-title":"Nat Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2004-11-4207","article-title":"Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells","volume":"106","author":"S Schubbert","year":"2005","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"H Yuan","year":"2012","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"D Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/sj.onc.1206091","article-title":"Studying the pathogenesis of BCR-ABL+ leukemia in mice","volume":"21","author":"RA Van Etten","year":"2002","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.seminoncol.2005.04.010","article-title":"Hematopathologic findings in chronic idiopathic myelofibrosis","volume":"32","author":"J Thiele","year":"2005","journal-title":"Semin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"H Zhang","year":"2012","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.immuni.2013.02.018","article-title":"Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice","volume":"38","author":"CL Abram","year":"2013","journal-title":"Immunity"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"A Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1182\/blood-2011-07-365601","article-title":"Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome","volume":"118","author":"P Nurden","year":"2011","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/leu.2011.251","article-title":"IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes","volume":"26","author":"A Pardanani","year":"2012","journal-title":"Leukemia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/leu.2009.167","article-title":"Identification of a novel TEL-Lyn fusion gene in primary myelofibrosis","volume":"24","author":"H Tanaka","year":"2010","journal-title":"Leukemia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.2011.08663.x","article-title":"Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis","volume":"153","author":"Y Takeda","year":"2011","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nchembio.775","article-title":"BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia","volume":"8","author":"O Hantschel","year":"2012","journal-title":"Nat Chem Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:45:58Z","timestamp":1540244758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077542"}},"subtitle":[],"editor":[{"given":"Emilio","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077542","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}